Medical equipment maker Gerresheimer falls after UBS downgrades to 'sell'

Gerresheimer AG

24/02/2026 10:11

** Shares of German medical equipment maker Gerresheimer GXIG.DE down 4.2% after UBS downgrades stock to "sell" from "neutral"

** The broker says GXIG faces uncertainty over its financials and deleveraging plans

** Adds the possible sale of U.S. packaging business Centor would dilute margins while the moulded glass segment sale "looks like a more challenging asset to sell given end market weakness"

** After multiple profit warnings and delay of its annual report following an investigation from the German market regulator, UBS sees a wide range of outcomes, including further delay in co's annual report

** The outcomes we think are skewed to the downside on balance, with higher risks and lower growth - UBS

** Of 17 analysts covering Gerresheimer AG, four rate the stock "buy" or higher, ​nine rate it "hold" and four rate it "sell" or "strong sell" - LSEG-compiled data

 (Reporting by Emanuele Berro)

 ((emanuele.berro@thomsonreuters.com))